# Microbial Products (Synthetic Biology) Sector

Canonical URL: https://biopharmsignal.com/sector/microbial-products-synthetic-biology

Microbial Products (Synthetic Biology) groups companies using engineered microbes, microbial systems, or synthetic biology workflows to produce therapeutic or industrial biological products. It is a cross-disciplinary category that blends platform biology with scalable manufacturing logic.

Companies currently grouped under Microbial Products (Synthetic Biology): 1

## Recent Sector News

- 2026-07-29 11:00 EST — SYBX — [Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement](https://biopharmsignal.com/news/SYBX/synlogic-and-caldera-therapeutics-announce-merger-agreement-and-concurrent-priva-11695f09) — Source: Synlogic
- 2024-11-12 21:35 EST — SYBX — [Synlogic Reports Third Quarter 2024 Financial Results](https://biopharmsignal.com/news/SYBX/synlogic-reports-third-quarter-2024-financial-results) — Source: Synlogic
- 2024-08-08 11:00 EST — SYBX — [Synlogic Reports Second Quarter 2024 Financial Results](https://biopharmsignal.com/news/SYBX/synlogic-reports-second-quarter-2024-financial-results) — Source: Synlogic
- 2024-05-14 11:00 EST — SYBX — [Synlogic Reports First Quarter 2024 Financial Results](https://biopharmsignal.com/news/SYBX/synlogic-reports-first-quarter-2024-financial-results) — Source: Synlogic
- 2024-03-19 11:00 EST — SYBX — [Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results](https://biopharmsignal.com/news/SYBX/synlogic-reports-fourth-quarter-and-full-year-2023-financial-results) — Source: Synlogic
- 2024-02-20 17:15 EST — SYBX — [Synlogic Adopts Limited Duration Stockholders Rights Plan](https://biopharmsignal.com/news/SYBX/synlogic-adopts-limited-duration-stockholders-rights-plan) — Source: Synlogic
- 2024-02-08 21:15 EST — SYBX — [Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update](https://biopharmsignal.com/news/SYBX/synlogic-announces-decision-to-discontinue-synpheny-3-study-and-provides-corporate-update) — Source: Synlogic
- 2024-02-02 17:00 EST — SYBX — [Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria](https://biopharmsignal.com/news/SYBX/synlogic-announces-publication-of-preclinical-and-clinical-data-for-synb1353-as-a-potential-treatment-for-classical-homocystinuria) — Source: Synlogic
- 2024-01-04 12:00 EST — SYBX — [Synlogic Provides Corporate Update and Outlook for 2024](https://biopharmsignal.com/news/SYBX/synlogic-provides-corporate-update-and-outlook-for-2024) — Source: Synlogic
- 2023-12-27 12:00 EST — SYBX — [Synlogic Announces Contract with the Air Force Research Lab](https://biopharmsignal.com/news/SYBX/synlogic-announces-contract-with-the-air-force-research-lab) — Source: Synlogic
- 2023-12-07 12:00 EST — SYBX — [Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023](https://biopharmsignal.com/news/SYBX/synlogic-announces-abstract-accepted-for-poster-presentation-at-the-international-conference-on-microbiome-engineering-2023) — Source: Synlogic

## Companies

- [SYBX](https://biopharmsignal.com/company/SYBX) — Synlogic